Gregory L. Verdine, Director at ENANTA PHARMACEUTICALS INC (ENTA), bought 3,324 shares at $14.00 ($47K) on 2013-03-26, disclosed to the SEC on 2013-03-28.
Open-market purchase of $47k ENTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| WVE | SELL | 2025-06-13 | $209K | — | Filing → |
| WVE | SELL | 2019-11-22 | $1.7M | — | Filing → |
| WVE | SELL | 2018-11-16 | $996K | — | Filing → |